Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
US cancer registries study of smoldering myeloma finds mean incidence 0.69 (95% CI 0.67–0.70)/100,000 person-years, steady increase from 0.59 in 2012-0.90 in 2022 (p=0.01); increased with age through 75–79, decreased after 80.”
Title: Trends in Smoldering Myeloma Incidence in the United States From Cancer Registries, 2012–2022
Authors: Rong Wang, Amy J. Davidoff, Martin Schoen, John H. Huber, Eric J. Feuer, Jennifer Ruhl, Natalia Neparidze, Xiaomei Ma, Su-Hsin Chang, Shi-Yi Wang
You can read the Full Article in the American Journal of Hematology.
You can find more posts featuring Robert Orlowski on OncoDaily.
